Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
Open Access
- 8 June 2019
- journal article
- case report
- Published by Elsevier BV in JAAD Case Reports
- Vol. 5 (6), 518-521
- https://doi.org/10.1016/j.jdcr.2019.03.024
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritisPediatric Rheumatology, 2017
- Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF InhibitorsNew England Journal of Medicine, 2017
- Tofacitinib or Adalimumab versus Placebo for Psoriatic ArthritisNew England Journal of Medicine, 2017
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF inductionArchiv für dermatologische Forschung, 2017
- Pustulotic arthro‐osteitis associated with palmoplantar pustulosisThe Journal of Dermatology, 2013
- Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010Journal of the American Academy of Dermatology, 2012
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of actionArthritis Care & Research, 2008